Cargando…

A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

Detalles Bibliográficos
Autores principales: Armstrong, April W., Soliman, Ahmed M., Betts, Keith A., Wang, Yan, Gao, Yawen, Stakias, Vassilis, Puig, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674807/
https://www.ncbi.nlm.nih.gov/pubmed/36271222
http://dx.doi.org/10.1007/s13555-022-00812-z
_version_ 1784833230044659712
author Armstrong, April W.
Soliman, Ahmed M.
Betts, Keith A.
Wang, Yan
Gao, Yawen
Stakias, Vassilis
Puig, Luis
author_facet Armstrong, April W.
Soliman, Ahmed M.
Betts, Keith A.
Wang, Yan
Gao, Yawen
Stakias, Vassilis
Puig, Luis
author_sort Armstrong, April W.
collection PubMed
description
format Online
Article
Text
id pubmed-9674807
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-96748072022-11-20 A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis Armstrong, April W. Soliman, Ahmed M. Betts, Keith A. Wang, Yan Gao, Yawen Stakias, Vassilis Puig, Luis Dermatol Ther (Heidelb) Letter Springer Healthcare 2022-10-21 /pmc/articles/PMC9674807/ /pubmed/36271222 http://dx.doi.org/10.1007/s13555-022-00812-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Armstrong, April W.
Soliman, Ahmed M.
Betts, Keith A.
Wang, Yan
Gao, Yawen
Stakias, Vassilis
Puig, Luis
A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_full A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_fullStr A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_full_unstemmed A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_short A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_sort response to: letter to the editor regarding long-term benefit–risk profiles of treatments for moderate-to-severe plaque psoriasis: a network meta-analysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674807/
https://www.ncbi.nlm.nih.gov/pubmed/36271222
http://dx.doi.org/10.1007/s13555-022-00812-z
work_keys_str_mv AT armstrongaprilw aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT solimanahmedm aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT bettskeitha aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT wangyan aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT gaoyawen aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT stakiasvassilis aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT puigluis aresponsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT armstrongaprilw responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT solimanahmedm responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT bettskeitha responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT wangyan responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT gaoyawen responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT stakiasvassilis responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT puigluis responsetolettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis